This study is aimed to evaluate the effect of the optimal heart team implementation protocol on the stability of decision-making for patients with complex coronary artery disease.
Current guidelines recommend a heart team in the decision making for patients with complex coronary artery disease (CAD). Previous study reported that the agreement between heart teams for revascularization decision-making in complex CAD patients was moderate. Potential factors associated with decision discrepancies were summarized in several aspects and a detailed heart team implementation protocol was generated and further validation is needed. This study is designed to evaluate the effect of the optimal heart team implementation protocol on the stability of decision-making for patients with complex coronary artery disease.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
84
Heart teams in the experimental group will be established and trained based on the optimal heart team implementation protocol. The protocol included instructions on specialist selection, specialist training, team composition, team training and formal implementation precess.
National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, Beijing Municipality, China
Overall percent agreement
The proportion of patients who received unanimous decision recommendations from the heart team
Time frame: through study completion, an average of 1 year
Kappa value of heart team decision-making
Fliess's (more than 2 raters) and Cohen's (2 raters) kappa coefficients to evaluate inter-team, inter-specialist, and inter-round agreement for treatment decisions.
Time frame: through study completion, an average of 1 year
Inappropriate decision rate
According to the American College of Cardiology/American Association for Thoracic Surgery/American Heart Association 2017 Appropriate Use Criteria for coronary revascularization, the inappropriate decision rate od decision-making
Time frame: through study completion, an average of 1 year
Compliance rate in real-world treatment
Compliance is defined as the patient's actual treatment meeting the recommendations of either heart team
Time frame: through study completion, an average of 1 year
Reproducibility of decision-making
All cases will be discussed by the same heart team to evaluate the intra-team consistency in decision-making.
Time frame: At 1-month after first phase of heart team meeting
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.